Cedric Hermans: This Should Be a Great Discussion — Do Not Hesitate to Join Us
Cedric Hermans, Head of Haemophilia Centre at the Cliniques Universitaires Saint-Luc in Brussels, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”This should be a great discussion
Do not hesitate joining us.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Did you hear the news? Our sister RPTH Journal has an exciting Research Recap coming up next week! Join to hear from Robert Sidonio, MD,MSc, author of the recently published RPTH article: “Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.”
Cedric Hermans MD PhD FRCP (Lon,Edin), author of related commentary on the topic, will also give a brief response. They will be led in a conversation with moderator Michael Makris, the RPTH Editor-in-Chief.
Excited? So are we! Read before you watch:
Secure your spot here.”
Title1: Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
Authors: Robert F. Sidonio, Jr., Guy Young, Carmen Escuriola Ettingshausen, Johnny Mahlangu, Margareth C. Ozelo, Alok Srivastava, Jerzy Windyga, Hye–Youn Lee, Aurelia Lelli, Steven W. Pipe
Title2: Cautious use of activated prothrombin complex concentrate in patients receiving emicizumab: new evidence and clinical considerations
Author: Cedric Hermans
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!